All participants | Male | Female | ||||
---|---|---|---|---|---|---|
AD | MCI | AD | MCI | AD | MCI | |
Q4 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Q3 | 0.58 (0.46–0.78) | 0.36 (0.26–0.49) | 0.54 (0.39–0.74) | 0.31 (0.22–0.39) | 0.63 (0.46–0.85) | 0.40 (0.29–0.53) |
Q2 | 0.51 (0.36–0.73) | 0.29 (0.21–0.40) | 0.48 (0.34–0.63) | 0.26 (0.20–0.36) | 0.54 (0.39–0.75) | 0.33 (0.24–0.45) |
Q1 | 0.50 (0.35–0.68) | 0.16 (0.10–0.21) | 0.45 (0.32–0.67) | 0.14 (0.11–0.21) | 0.53 (0.39–0.70) | 0.17 (0.12–0.24) |
Pfor trend | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |